z-logo
open-access-imgOpen Access
Which anti-TNF is most effective for my patient? Which one should I choose?
Author(s) -
Melih Pamukçu,
Rabia Aydoğan Baykara
Publication year - 2021
Publication title -
journal of surgery and medicine
Language(s) - English
Resource type - Journals
ISSN - 2602-2079
DOI - 10.28982/josam.984025
Subject(s) - golimumab , adalimumab , etanercept , medicine , rheumatoid arthritis , erythrocyte sedimentation rate , concomitant , infliximab , antirheumatic drugs , tumor necrosis factor alpha , retrospective cohort study , surgery , antirheumatic agents

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom